Diversified Trust Co Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Diversified Trust Co grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 14.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,745 shares of the healthcare conglomerate’s stock after purchasing an additional 6,158 shares during the quarter. UnitedHealth Group comprises approximately 0.6% of Diversified Trust Co’s portfolio, making the stock its 25th largest holding. Diversified Trust Co’s holdings in UnitedHealth Group were worth $25,164,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $27,000. Global Wealth Strategies & Associates increased its stake in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the last quarter. West Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $32,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $37,000. Finally, Quarry LP boosted its stake in UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 37 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.1 %

Shares of NYSE:UNH traded up $0.76 during trading on Tuesday, hitting $514.43. 1,255,779 shares of the company were exchanged, compared to its average volume of 3,133,696. The firm’s 50 day moving average price is $558.76 and its 200-day moving average price is $561.51. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The stock has a market capitalization of $473.42 billion, a P/E ratio of 33.51, a PEG ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.56 earnings per share. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analysts Set New Price Targets

Several brokerages have recently commented on UNH. Truist Financial decreased their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday. KeyCorp started coverage on UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target for the company. Deutsche Bank Aktiengesellschaft increased their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Finally, Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $627.58.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.